Flexible regulatory pathways and key CMC considerations to commercialize cell and gene therapy products
Flexible regulatory pathways and key CMC considerations to commercialize cell and gene therapy products
해당 웨비나에서는 세포 및 유전자 치료제의 인허가 절차를 안내하고 이에 대처하는 방법을 설명합니다.

Added Date:

2022-10-16

Filters:

Filter Category Filter Values
Specialty
  • Regulatory
Capability
  • Viral Vectors
Asset Type
  • Webinar on-demand
Expert
  • Monica Commerford PhD
Country
  • All
Region
  • Global
Market Category
  • Advanced therapy

Country Availability:


()

Gated Form:

None Set